CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Metagenics, Inc.

For profitWebsite ↗

Also known as: Metagenics Europe | Metagenics, Inc. | MetaProteomics LLC | MetaProteomics / Metagenics | MetaProteomics / Metagenics / FMRC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Jan 22, 2021

Timeline

1980s

Jun 1, 1983
Metagenics, Inc.— Founded

Drugs by trial phase (5 distinct, 5 trials)

Phase 1 (1 own, 0 via acquisition)

icosapent ethyl

Other trials (4 own, 0 via acquisition)

Indications

Studied for

Chronic Pain

Recent trials (9)

NCT04734288CollaboratorN/AJan 22, 2021
NCT04734288Lead sponsorN/AJan 22, 2021
NCT03983772Overall official - principal investigatorN/AJun 14, 2019
NCT03983772Lead sponsorN/AJun 14, 2019
NCT02683850CollaboratorEarly Phase 1Jan 1, 2016
NCT01671254Overall official - principal investigatorN/AAug 1, 2012
NCT01671254Lead sponsorN/AAug 1, 2012
NCT01656681Overall official - principal investigatorN/AMay 1, 2011
NCT01656681Lead sponsorN/AMay 1, 2011

Details

Founded: Aliso Viejo, CA, US Jun 1, 1983
Last known activity: Jan 22, 2021